A recent paper by Takada, published on August 3, 2024, highlights significant safety concerns regarding COVID-19 vaccines, particularly about myocarditis. The Reporting Odds Ratios (ROR) indicate that the ROR for myocarditis is 15 for the Pfizer vaccine and a concerning 54 for Moderna, suggesting that the safety profile of these vaccines diverges significantly from that of a placebo. The analysis implies that the odds of experiencing myocarditis are 15 times higher with Pfizer and 3.6 times worse with Moderna, deeming Moderna especially hazardous. This alarming data raises questions about the lack of transparency from health authorities, who are not educating the public about these serious adverse event ratios. The author argues that the FDA and CDC prioritize protecting pharmaceutical companies over public safety, calling for a comprehensive ROR analysis of the most serious adverse events associated with COVID-19 vaccines. Ultimately, this paper underscores the urgent need for public awareness regarding vaccine safety and the potential risks involved.

Editor’s Note: In a world where “trust the science” has become a mantra, it’s astonishing to see a new paper by Takada drop like a bombshell on the vaccine narrative, revealing that the Reporting Odds Ratio (ROR) for myocarditis is 15 for Pfizer and a staggering 54 for Moderna. That’s right—54! If you thought ordering a double shot of espresso was risky, how about a vaccine with a ROR that screams “train wreck”? The absurdity here is palpable: a drug with a ROR of 54 is about as safe as juggling chainsaws at a circus. Yet, our health authorities remain eerily silent, as if they’re complicit in some grand illusion where the safety of the populace is overshadowed by corporate interests. Where’s the urgent public education on these shocking figures? Perhaps they’re too busy polishing their relationships with pharmaceutical giants to care. If you’re still holding Moderna stock, you might want to take a cue from the RORs and cut your losses—before the market catches up with the reality that health authorities seem intent on keeping under wraps. The public deserves better than this deafening silence; they deserve transparency, clarity, and a real dialogue about the risks they face. It’s high time we demand a ROR analysis for serious adverse events by brand—because ignoring the facts doesn’t just endanger lives; it undermines the very fabric of public trust.

Read Original Article